Should transarterial chemoembolization be given before or after intensity-modulated radiotherapy to treat patients with hepatocellular carcinoma with portal vein tumor thrombus? a propensity score matching study

BACKGROUND AND OBJECTIVE: To compare the survival outcomes of patients with hepatocellular carcinoma (HCC) with portal vein tumor thrombus (PVTT) who received transarterial chemoembolization (TACE) before or after intensity-modulated radiotherapy (IMRT). METHODS: During the study period, the surviva...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiaolong, Guo, Weixing, Guo, Lei, Lau, Wan Yee, Ge, Naijian, Wang, Kang, Cheng, Shuqun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5966265/
https://www.ncbi.nlm.nih.gov/pubmed/29849959
http://dx.doi.org/10.18632/oncotarget.25224

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5966265/
https://www.ncbi.nlm.nih.gov/pubmed/29849959
http://dx.doi.org/10.18632/oncotarget.25224

Ejemplares similares